Authors
Latest:
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK InhibitorsThis article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
Latest:
New Therapeutic Agents and Final Thoughts on DEDA panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
Latest:
A Brief Overview of Loop Diuretics Used in Heart FailureThe combination of loop diuretics with other drugs that act at different pharmacologic targets has been shown to improve diuretic response in patients with heart failure.
Latest:
Understand the Effects of Topical Nasal Decongestants on Blood PressureBecause decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.
Latest:
Counsel Patients Who Have Questions About Maternal RSV ImmunizationsRSVpreF is currently the only FDA-approved RSV vaccine for pregnant individuals.
Latest:
Gene Therapies Hold Promise for Neuromuscular and Other Rare DiseasesChallenges remain, however, to therapy development for a limited patient population.
Latest:
Building a Path to Cure for Patients With NSCLC Who Have Never SmokedHow patients acquire NSCLC plays a role in health outcomes, with never-smoker patients having genetically different disease than the same disease in smokers.
Latest:
5 Ways Pharmacies Can Use Texting to Boost Patient EngagementTexting with patients can help to improve pharmacy processes while creating better user experiences.
Latest:
New Treatment Options Are on the Horizon for β-ThalassemiaGene therapies in late-stage development may soon provide hope for a cure.
Latest:
Helping Pharmacists Excel in the ‘New Normal’With more work and less staff, we need to examine how we can better support pharmacists in the new normal brought on by COVID-19.
Latest:
Securing the Supply Chain: The DSCSA and the New Importation Policy in FloridaIn January 2024, Florida became the only state to allow the importation of medications for public use.
Latest:
Considerations for Environmentally Conscious Pharmacy StudentsEnvironmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Latest:
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood CancerAdvances, challenges, and promising innovations emerge.
Latest:
The Role of Medicinal Plants in Modern PharmacyResearchers are working to solve consistency and ecological and ethical concerns in pharmaceutical formulations
Latest:
Recognize the Value of Health Care VolunteersThe health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
Latest:
Navigating the Rapid Growth of Specialty Drugs: Opportunities, Challenges, and the Path AheadHigh-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.
Latest:
It Is Time to Consider Alternatives to Discipline ProgramsProfessional assistance programs provide pathway for health care professionals to return to practice following treatment for substance use disorder.
Latest:
Understanding Pharmacogenomics Is Essential for Personalized CarePharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.
Latest:
Bacteroidetes: The Jekyll and Hyde of the Human Gut MicrobiomeThe relative abundance of gram-negative Bacteroidetes to other phyla, such as gram-positive Firmicutes, is essential to maintain biodiversity and human gut health.
Latest:
Therapies Under Investigation for Waldenström MacroglobulinemiaThe exciting therapies in the pipeline that are thought to target novel mechanisms in Waldenström macroglobulinemia.
Latest:
Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical ConsiderationsThis article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Latest:
Insights on the UK's MHRA International Recognition ProcedureThe UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Latest:
New Frontiers in Technology: AI Use in Clinical Trial Patient Recruitment in Health SystemsAI is significantly enhancing the efficiency of identifying and enrolling patients.
Latest:
Long Story Short: Cellulitis Can Be Treated in Less Than a WeekDuration of therapy may be just 5 to 6 days for patients without risk factors for complications.
Latest:
One Year Later: Key Issues Impacting Health System Pharmacies During the COVID-19 Vaccine RolloutThis vaccine rollout has become even more crucial for the US health care system, as new mutations of the coronavirus continue to emerge.
Latest:
How Data Can Help Demonstrate the Value of the Health-System Specialty PharmacyInsurers, accountable care organizations, and manufacturers increasingly look for demonstrable clinical outcomes as proof for reimbursement or access to limited distribution networks.
Latest:
As Shortages Continue, Suppliers, Hospitals, and Health Systems Look for New SolutionsHospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.
